NEW YORK (GenomeWeb News) – Life Technologies recently acquired privately held Cytonix, a microfluidics technologies firm, the firm said earlier this week in its second-quarter earnings statement.

Life Technologies provided few details about the acquisition of the Beltsville, Md.-based company. However, it said that it acquired the firm for its intellectual property related to its microfluidics-based digital polymerase chain reaction technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.